Piper Sandler analyst Matt O'Brien increased the price target for Glaukos Corporation (NYSE:GKOS) shares to $180 from the previous target of $140, while maintaining an Overweight rating on the stock.

The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...

Target has announced it is rolling back its diversity, equity and inclusion (DEI) policies, becoming the latest corporation ...

BOSTON, MA, USA I1, 2025 I Antennova, a clinical-stage biotech company focused on oncology today announced the presentation of latest data from ...

The FDA says about 2,756 jars of First Aid Beauty Ultra Repair Cream Coconut Vanilla are being recalled due to a deviation from Current Good Manufacturing Practice regulations, which regulates quality ...

Over 35 years after the first study linking Red 3 to thyroid cancer in rats was published, the US is beginning to wean it out ...

Dr. Dorothy Fink, the acting secretary for the Department of Health and Human Services under President Donald Trump, has ...

The Food and Drug Administration released on Tuesday its long-awaited proposal to require food manufacturers to put some ...

By leveraging this capability, AlphaMeld Corporation has successfully progressed several candidates from target identification to pre-IND within just 6-9 months. Biologics Design Capabilities: ...

Target (TGT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Absci Corporation ... optimize target selection and validate therapeutic hypotheses using extensive biomedical datasets and patient-derived organoids. Absci’s generative AI Drug Creation ...

On January 7 th, Piper Sandler analyst James Callahan reiterated an “Overweight” rating on AppLovin Corporation (NASDAQ:APP) with a $400.00 price target. Applovin leverages AI-powered ...